- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02761603
Healthy Aging Practice-centered Instruction Cardiovascular Health Investigation (HAPI-CHI) (HAPI-CHI)
January 20, 2022 updated by: Laura S. Redwine, PhD, University of California, San Diego
Autonomic and Immuno-Vascular Mechanisms of Antihypertensive Effects of Tai Chi
Over 30% of American adults have hypertension (HTN) (high blood pressure), and the rate increases considerably with age; 64% of men and 78% of women over 65 have HTN.
High blood pressure associated with HTN can force of the blood against artery walls with enough pressure that it can eventually cause health problems, such as heart disease and stroke.
HTN is one of the most significant causes of early death worldwide and one of the most preventable causes of death.
Many studies reveal that lowering blood pressure (BP) reduces the incidence of diseases of the heart and blood vessels.
Non-drug related treatments are known to reduce BP which can have a great effect on public health.
Research suggests that Tai Chi (TC) is effective in lowering BP in patients with HTN, but because of the low quality of existing studies there is no definite proof.
Also, it is not known how TC reduces BP.
One possibility is that TC practice, which is shown to reduce psychological distress such as anxiety and depression and reduce the body's responses to stress, can improve the balance of the autonomic nervous system (the part of your nervous system that controls beating of the heart and the widening or narrowing of blood vessels).
This may lead to lower BP.
The investigators plan to investigate the pathways among autonomic, blood vessel, immune and psychological factors in relation to BP changes in response to 12-weeks of TC compared with Healthy Aging Practice-centered Education (HAP-E).
250 older adults (60+ years old) with mild HTN will be enrolled, and the investigators will take several measurements of heart and nervous system functioning.
The investigators hypothesize that performing TC for 12 weeks will result in autonomic "re-regulation" which will improve BP and blood vessel health (Aim 1) and sympathetic nervous system (part of the nervous system that serves to speed up heart rate, contract blood vessels, and raise blood pressure) regulation of the immune system (Aim 2).
Lastly, the investigators hypothesize that psychological factors will be related to TC effects on autonomic regulation (Aim 3).
Findings from the investigators study will hopefully shed light on the pathways by which TC reduces BP.
Also, the particular effects of TC ("meditative movement") in an older, "hard-to-treat" hypertensive population will be better understood.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
250
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 1. SBP≥130 but overall BP ≤ 170/110;
- Able to perform light to moderate exercise;
- Able to give informed consent;
- Able to complete study assessments as described;
- Understand study procedures and to comply with them for the entire length of the study;
- 5. 60+ years;
- Able to complete written questionnaires without assistance (reading devices okay);
- Have not had a fall in that resulted in hospitalization in the past 12 months;
- Willing to be randomized to TC or HAP-E;
- Able to attend regular study activities at the center and/or UCSD.
Exclusion Criteria:
- Currently performing meditation for more than 15 minutes at a time 2X/week or more);
- Currently performing moderate exercise (enough to work up a sweat) for more than 15 minutes 2X/week or more.
- Oxygen-dependent COPD;
- Stroke, cerebral neurologic impairment, cardiac surgery or MI within the past year;
- Current use of mood stabilizers, or antipsychotics;
- Medications (steroids) and conditions affecting our immune assays or our physiological measures of vascular function (anti-cholinergics);
- Severe kidney disease;
- Current cancer diagnosis or treatment;
- Insulin-dependent diabetes mellitus;
- Meets criteria for bipolar disorder, schizophrenia, substance use disorder;
- Suicidality;
- Inability to read and write in English;
- Inability to provide written informed consent;
- Inability to adequately answer questions on the post-consent assessment;
- Current smoker;
- Body Mass Index > 40 kg/m2;
- Currently meets criteria for major depressive episode (per patient self-report of clinical diagnosis by a professional);
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Healthy Aging Practice-centered Instruction (HAPI)
24 hours of group instruction in which experts present on a variety of health-related topics followed by class discussion, goal-setting, and goal review.
Themes will include: sleep, nutrition, mental health, social support, bone-health, diabetes prevention, cognitive wellness, and resilience.
|
Sessions will include interactive activities derived from the CDC's "Program to Encourage Active and Rewarding LiveS (PEARLS)" and will include lectures based on health-related topics from presentations given by experts as part of the UC San Diego Stein Institute of Aging's Successful Aging project.
The PEARLS Problem Solving Treatment (PST) group discussions will be facilitated by a trained instructor in order for participants to identify problems or barriers they have in engaging in healthy behaviors relevant to each of 12 topic areas (e.g.
sleep, nutrition, mental health, social support, bone health, diabetes prevention, cognitive wellness, and resilience).
Each session will be composed of: Successful Aging video (45 min), discussion (40 min), and identifying problem solving strategies (25 min) with a homework assignment each week, for a total of 24 hours of in-class instruction and discussion.
|
|
Experimental: Tai Chi (CHI)
24 hours of group instruction in 8 meditative Tai Chi movements.
|
Sessions will include expert instruction in the brief Yang-style 8-form Tai Chi meditative movements.
Each class will include a 10-minute warm-up and cool-down plus 40 minutes of Tai Chi instruction and or practice, for a total of 24 hours of in-class instruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure
Time Frame: Pre- to post-intervention (12 weeks)
|
Change From Pre-intervention to Post-intervention in Blood Pressure (mmHg)
|
Pre- to post-intervention (12 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroke Volume
Time Frame: Pre- to post-intervention (12 weeks)
|
Change From Pre-intervention to Post-intervention in Stroke Volume (mL)
|
Pre- to post-intervention (12 weeks)
|
|
Cardiac Output
Time Frame: Pre- to post-intervention (12 weeks)
|
Change From Pre-intervention to Post-intervention in Cardiac Output (mL/min)
|
Pre- to post-intervention (12 weeks)
|
|
Total Peripheral Resistance (TPR)
Time Frame: Pre- to post-intervention (12 weeks)
|
Change From Pre-intervention to Post-intervention in TPR (mmHg·min/l)
|
Pre- to post-intervention (12 weeks)
|
|
Ejection Fraction (EF)
Time Frame: Pre- to post-intervention (12 weeks)
|
Change From Pre-intervention to Post-intervention in EF (%)
|
Pre- to post-intervention (12 weeks)
|
|
Pulse Wave Velocity (PWV)
Time Frame: Pre- to post-intervention (12 weeks)
|
Change From Pre-intervention to Post-intervention in PWV
|
Pre- to post-intervention (12 weeks)
|
|
Heart Rate Variability (HRV)
Time Frame: Pre- to post-intervention (12 weeks)
|
Change From Pre-intervention to Post-intervention in HRV
|
Pre- to post-intervention (12 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
May 1, 2021
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
April 29, 2016
First Submitted That Met QC Criteria
May 3, 2016
First Posted (Estimate)
May 4, 2016
Study Record Updates
Last Update Posted (Actual)
January 21, 2022
Last Update Submitted That Met QC Criteria
January 20, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HL126056 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Healthy Aging Practice-centered Instruction (HAPI)
-
Parc Sanitari Pere VirgiliRecruitingFrailty | Healthy Aging | Older AdultsSpain